Genesis Care buyout offers loan buyers rare juice and a Chinese shareholder

By Owen Sanderson
18 Feb 2020

Australian healthcare business Genesis Care is borrowing A$1.4bn-equivalent to fund the buyout of 21st Century Oncology’s US business, giving loan investors a rare chance to put money to work at a spread north of 400bp.

The Sydney-based company is 21% owned by KKR, whose capital markets operation is leading the syndication with Morgan Stanley, but its largest shareholder, at 41%, is China Resources, a conglomerate with holdings in beer, real estate, energy, retail and meat.

Genesis agreed to buy the US business of ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access:

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: or find out more online here.